BAM15
Neutral, BioHarmony verdict
BioHarmony score 5.0 out of 10
BAM15 is an experimental mitochondrial uncoupler that reversed diet-induced obesity and insulin resistance in mice without raising body temperature, the effect that made 2,4-dinitrophenol lethal. It has never been tested in a single human, and is sold only as an unregulated research chemical.
Read full reportWhat is BAM15?
BAM15 is an experimental compound that makes cells burn more fuel by letting protons leak across the inner mitochondrial membrane. In mice it reversed obesity and insulin resistance without the overheating that killed people who took its predecessor.
From the BioHarmony report, reviewed Sep 9, 2026.
Saved on this device only.
How it is thought to work
Mitochondrial uncoupling without plasma-membrane depolarization
Safety watch-outs
- Fever, profuse sweating or a racing heart: stop immediately and seek care, since that is the DNP toxicity pattern.
- Confusion, muscle rigidity or dark urine: stop and seek emergency care, since that pattern points to a rhabdomyolysis or hyperthermia…
- Any product without a verified certificate of analysis: do not take it, because no approved supply of BAM15 exists anywhere.
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for BAM15 yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (3)
Attributed viewpoints, separate from primary research.
- Why Longevity Protocols Fail: Peptides, Stacks & the Science of Precision Alex Kikel,
- Unleashing BAM15 The Next-Gen Fat Burning Miracle Hunter Williams,
- BAM15 Benefits: Mitochondrial Uncoupler for Fat Loss Jay Campbell,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
BAM15 is a small-molecule mitochondrial uncoupler studied in cells and animal models. Published evidence does not establish human safety, effectiveness, or dosing.
Primary sources
- Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice PubMed / Nature Communications,
Related peptides for weight & metabolic
- 6.1TirzepatideTirzepatide is a once-weekly subcutaneous dual GIP plus GLP-1 receptor agonist with unusually large weight-loss and glycemic effects.
- 6.0MOTS-cMOTS-c is a 16-amino-acid mitochondrial-derived peptide discovered in Lee 2015 that activates AMPK through the folate and purine pathway.
- 6.0TesamorelinTesamorelin is a stabilized GHRH analog that reduced visceral adipose tissue in the landmark Falutz 2007 HIV lipodystrophy Phase 3 trial and has newer support for…
- 5.9Semaglutide (GLP-1 Agonist)Semaglutide is a prescription GLP-1 receptor agonist that produced 14.9% mean weight loss in STEP-1 and cut 3-point MACE by 20% in SELECT, but the 5.5-6.0/10 score holds…
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.